[DISCLOSURE] Kyongbo Pharm (214390) said on Sept. 21 that it has obtained a patent on manufacturing process of its hyperlipidemia treatment, based on rosuvastatin calcium.
Kyongbo Pharm earns patent for hyperlipidemia treatment manufacturing process
Sept. 21, 2016 - 15:44:25
![[Graphic News] Hygiene products market surpasses W3tr for first time](https://wimg.heraldcorp.com/news/cms/2026/09/01/news-p.v1.20260901.f0ded17ebd9e4a1bb15da6ec364e4ff3_T1.gif?type=h&h=800)
